Pharmaceutical Analytical Testing Outsourcing Market Research Report Information By Product (Finished Products and Active Pharmaceutical Ingredients), By Services (Bioanalytical Testing, Stability Testing, Method Development & Validation and others), By End-User (Biopharmaceutical Companies, Biotechnology Industry and Pharmaceutical), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032.

1 Executive Summary

2 Market Introduction

2.1 Scope of Study 15

2.2 Research Objective 15

2.3 List of Assumptions 16

3 Research Methodology

3.1 Research Process 17

3.2 Primary Research 18

3.3 Secondary Research 19

3.4 Market Size Estimation 20

4 Market Dynamics

4.1 Introduction 21

4.2 Drivers 22

4.2.1 Growing Pharmaceutical Industry 22

4.2.2 Increasing Demand for Analytical Details on Drugs and Process Development by Regulatory Agencies 22

4.2.3 Growing Prevalence of Cancer and Infectious Diseases 22

4.3 Restraints 23

4.3.1 High Cost of Drug Discovery 23

4.3.2 Inconsistency in the Quality of Products 23

4.4 Opportunity 23

4.4.1 Innovation and Launch of New Tests to Check the Quality of Products 23

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 24

5.1.1 Bargaining Power of Suppliers 24

5.1.2 Bargaining Power of Buyers 25

5.1.3 Threat of New Entrants 25

5.1.4 Threat of Substitutes 25

5.1.5 Intensity of Rivalry 25

5.2 Value Chain Analysis 26

5.2.1 Drug Discovery/Research 26

5.2.2 Clinical and Preclinical Trials 26

5.2.3 Manufacturing 27

5.2.4 Sales and Distribution 27

6 Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

6.1 Introduction 28

6.2 Raw Materials 30

6.3 Finished Products 30

6.4 Active Pharmaceutical Ingredients 31

7 Pharmaceutical Analytical Testing Outsourcing Market, By Services

7.1 Introduction 32

7.2 Bioanalytical Testing 34

7.3 Method Development & Validation 34

7.4 Stability Testing 35

8 Pharmaceutical Analytical Testing Outsourcing Market, By End User

8.1 Introduction 36

8.2 Pharmaceutical and Biopharmaceutical Companies 38

8.3 Biotechnology industry 38

9 Global Pharmaceutical Analytical Testing Outsourcing Market, By Region

9.1 Introduction 39

9.2 Americas 42

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.2.1 North America 44

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.2.1.1 US 47

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.2.1.2 Canada 48

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.2.2 South America 50

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3 Europe 52

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1 Western Europe 54

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.1 Germany 57

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.2 UK 58

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.3 France 60

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.4 Italy 61

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.5 Spain 63

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.1.6 Rest of Western Europe 64

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.3.2 Eastern Europe 66

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4 Asia Pacific 68

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.1 Japan 70

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.2 China 72

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.3 India 73

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.4 Australia 75

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.5 South Korea 76

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.4.6 Rest of Asia-Pacific 78

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.5 Middle East & Africa 80

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.5.1 Middle East 82

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

9.5.2 Africa 84

Pharmaceutical Analytical Testing Outsourcing Market, By Product Type

Pharmaceutical Analytical Testing Outsourcing Market, By Services

Pharmaceutical Analytical Testing Outsourcing Market, By End User

10 Competitive Landscape

10.1 Competitive Landscape 86

11 Company Profiles

11.1 Exova Group PLC 87

11.1.1 Company Overview 87

11.1.2 Financial Overview 87

11.1.3 Products/Services Offered 87

11.1.4 Key Developments 87

11.1.5 SWOT Analysis 88

11.1.6 Key Strategies 88

11.2 Boston Analytical 89

11.2.1 Company Overview 89

11.2.2 Financial Overview 89

11.2.3 Products/Services Offered 89

11.2.4 Key Developments 90

11.2.5 SWOT Analysis 90

11.2.6 Key Strategies 90

11.3 Charles River Laboratories International, Inc 91

11.3.1 Company Overview 91

11.3.2 Financial Overview 91

11.3.3 Products/Services Offered 92

11.3.4 Key Developments 92

11.3.5 SWOT Analysis 92

11.3.6 Key Strategies 92

11.4 West Pharmaceutical Services, Inc. 93

11.4.1 Company Overview 93

11.4.2 Financial Overview 93

11.4.3 Products/Services Offered 93

11.4.4 Key Developments 94

11.4.5 SWOT Analysis 94

11.4.6 Key Strategies 94

11.5 Merck KGaA 95

11.5.1 Company Overview 95

11.5.2 Financial Overview 95

11.5.3 Products/Services Offered 96

11.5.4 Key Developments 96

11.5.5 SWOT Analysis 96

11.5.6 Key Strategies 96

11.6 WuXi AppTec 97

11.6.1 Company Overview 97

11.6.2 Financial Overview 97

11.6.3 Products/Services Offered 97

11.6.4 Key Developments 98

11.6.5 SWOT Analysis 98

11.6.6 Key Strategies 98

11.7 Source BioScience 99

11.7.1 Company Overview 99

11.7.2 Financial Overview 99

11.7.3 Products/Services Offered 99

11.7.4 Key Developments 99

11.7.5 SWOT Analysis 100

11.7.6 Key Strategies 100

11.8 SGS SA 101

11.8.1 Company Overview 101

11.8.2 Financial Overview 101

11.8.3 Products/Services Offered 102

11.8.4 Key Developments 103

11.8.5 SWOT Analysis 103

11.8.6 Key Strategies 103

11.9 Toxikon 104

11.9.1 Company Overview 104

11.9.2 Financial Overview 104

11.9.3 Products/Services Offered 104

11.9.4 Key Developments 104

11.9.5 SWOT Analysis 105

11.9.6 Key Strategies 105

11.10 Eurofins Scientific 106

11.10.1 Company Overview 106

11.10.2 Financial Overview 106

11.10.3 Products/Services Offered 107

11.10.4 Key Developments 107

11.10.5 SWOT Analysis 108

11.10.6 Key Strategies 108

11.11 Pace Analytical Services, LLC 109

11.11.1 Company Overview 109

11.11.2 Financial Overview 109

11.11.3 Products/Services Offered 109

11.11.4 Key Developments 110

11.11.5 SWOT Analysis 110

11.11.6 Key Strategies 110

11.12 Intertek Group PLC 111

11.12.1 Company Overview 111

11.12.2 Financial Overview 111

11.12.3 Products/Services Offered 112

11.12.4 Key Developments 112

11.12.5 SWOT Analysis 112

11.12.6 Key Strategies 112

11.13 Pharmaceutical Product Development, LLC 113

11.13.1 Company Overview 113

11.13.2 Financial Overview 113

11.13.3 Products/Services Offered 113

11.13.4 Key Developments 113

11.13.5 SWOT Analysis 114

11.13.6 Key Strategies 114

12 Appendix

12.1 References 115

12.2 Related Reports 115

13 List of Tables

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 PRIMARY INTERVIEWS 18

TABLE 3 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 29

TABLE 4 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR RAW MATERIALS, BY REGION, 2023 TO 2030 (USD MILLION) 30

TABLE 5 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR FINISHED PRODUCTS, BY REGION, 2023 TO 2030 (USD MILLION) 30

TABLE 6 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR ACTIVE PHARMACEUTICAL INGREDIENTS, BY REGION, 2023 TO 2030 (USD MILLION) 31

TABLE 7 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 33

TABLE 8 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR BIOANALYTICAL TESTING, BY REGION, 2023 TO 2030 (USD MILLION) 34

TABLE 9 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR METHOD DEVELOPMENT & VALIDATION, BY REGION, 2023 TO 2030 (USD MILLION) 34

TABLE 10 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR STABILITY TESTING, BY REGION, 2023 TO 2030 (USD MILLION) 35

TABLE 11 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 37

TABLE 12 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023 TO 2030 (USD MILLION) 38

TABLE 13 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, FOR BIOTECHNOLOGY INDUSTRY, BY REGION, 2023 TO 2030 (USD MILLION) 38

TABLE 14 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 41

TABLE 15 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 42

TABLE 16 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 43

TABLE 17 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 43

TABLE 18 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 44

TABLE 19 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY COUNTRY, 2023 TO 2030 (USD MILLION) 44

TABLE 20 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 45

TABLE 21 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 46

TABLE 22 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 46

TABLE 23 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 47

TABLE 24 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 47

TABLE 25 US: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 48

TABLE 26 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 48

TABLE 27 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 49

TABLE 28 CANADA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 49

TABLE 29 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 50

TABLE 30 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 50

TABLE 31 SOUTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 51

TABLE 32 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 52

TABLE 33 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 53

TABLE 34 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 53

TABLE 35 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 54

TABLE 36 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY COUNTRY/REGION, 2023 TO 2030 (USD MILLION) 54

TABLE 37 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 55

TABLE 38 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 56

TABLE 39 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 56

TABLE 40 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 57

TABLE 41 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 57

TABLE 42 GERMANY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 58

TABLE 43 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 58

TABLE 44 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 59

TABLE 45 UK: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 59

TABLE 46 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 60

TABLE 47 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 60

TABLE 48 FRANCE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 61

TABLE 49 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 61

TABLE 50 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 62

TABLE 51 ITALY: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 62

TABLE 52 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 63

TABLE 53 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 63

TABLE 54 SPAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 64

TABLE 55 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 64

TABLE 56 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 65

TABLE 57 REST OF WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 65

TABLE 58 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 66

TABLE 59 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 66

TABLE 60 EASTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 67

TABLE 61 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 68

TABLE 62 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 69

TABLE 63 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 69

TABLE 64 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 70

TABLE 65 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 70

TABLE 66 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 71

TABLE 67 JAPAN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 71

TABLE 68 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 72

TABLE 69 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 72

TABLE 70 CHINA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 73

TABLE 71 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 73

TABLE 72 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 74

TABLE 73 INDIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 74

TABLE 74 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 75

TABLE 75 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 75

TABLE 76 AUSTRALIA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 76

TABLE 77 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 76

TABLE 78 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 77

TABLE 79 SOUTH KOREA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 77

TABLE 80 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 78

TABLE 81 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 78

TABLE 82 REST OF ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 79

TABLE 83 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 TO 2030 (USD MILLION) 80

TABLE 84 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 81

TABLE 85 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 81

TABLE 86 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 82

TABLE 87 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 82

TABLE 88 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 83

TABLE 89 MIDDLE EAST: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 83

TABLE 90 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 TO 2030 (USD MILLION) 84

TABLE 91 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 TO 2030 (USD MILLION) 84

TABLE 92 AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 TO 2030 (USD MILLION) 85

14 List of Figures

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET: STRUCTURE 16

FIGURE 3 RESEARCH PROCESS 17

FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES 20

FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET 21

FIGURE 6 PORTER’S FIVE FORCES MODEL 24

FIGURE 7 VALUE CHAIN: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET 26

FIGURE 8 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY PRODUCT TYPE, 2023 (%) 28

FIGURE 9 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY PRODUCT TYPE, 2023 & 2030 29

FIGURE 10 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY SERVICES, 2023 (%) 32

FIGURE 11 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY SERVICES, 2023 & 2030 33

FIGURE 12 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY END USER, 2023 (%) 36

FIGURE 13 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2023 & 2030 37

FIGURE 14 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2023 (%) 40

FIGURE 15 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2023 & 2030 40

FIGURE 16 AMERICAS: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2023 (%) 42

FIGURE 17 NORTH AMERICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY, 2023 (%) 45

FIGURE 18 EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2023 (%) 52

FIGURE 19 WESTERN EUROPE: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY/REGION, 2023 (%) 55

FIGURE 20 ASIA-PACIFIC: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY COUNTRY/REGION, 2023 (%) 68

FIGURE 21 MIDDLE EAST & AFRICA: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SHARE, BY REGION, 2023 (%) 80

FIGURE 22 GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, COMPANY SHARE ANALYSIS, 2023 (%) 86